Previous 10 | Next 10 |
2023-04-26 16:13:27 ET Accuray press release ( NASDAQ: ARAY ): FQ3 GAAP EPS of $0.01 beats by $0.02 . Revenue of $118.1M (+22.8% Y/Y) beats by $8.32M . Total revenue is expected in the range of $447.0 million to $455.0 million, vs. consensus of $449.71M, r...
Accuray Reports Fiscal 2023 Third Quarter Financial Results PR Newswire Company delivers record quarterly revenue and unit volume in Q3; Reiterates fiscal year guidance SUNNYVALE, Calif. , April 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY...
Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023 PR Newswire SUNNYVALE, Calif. , April 13, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2023, ended ...
2023-03-13 04:02:42 ET In wake of the bank's collapse with turmoil surrounding Silicon Valley Bank, several smaller pharma, biotech companies and health care equipment have come out and said they have exposure to FDIC-shuttered Silicon Valley Bank ( SIVB ). Among the biotec...
Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference PR Newswire Company to Take Part in Fireside Chat Tuesday, March 14, 2023 at 1:00pm PST / 4:00pm EST SUNNYVALE, Calif. , March 8, 2023 /PRNewswire...
Accuray to Participate in the Cowen 43rd Annual Health Care Conference PR Newswire Company to Take Part in Fireside Chat Monday, March 6, 2023 at 10:30am PST / 1:30pm EST SUNNYVALE, Calif. , Feb. 21, 2023 /PRNewswire/ -- Accuray Incorporated...
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer PR Newswire SUNNYVALE, Calif. , Feb. 16, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announ...
Shares of Accuray (NASDAQ: ARAY) were up as much as 17.6% on Thursday. The medical instruments maker, which specializes in radiation oncology machines, released its fiscal 2023 second-quarter earnings report late Wednesday. So far this year, shares are up more than 35%. In the second-...
Summary Accuray's revenue did fall year-over-year as reported, but the company beat expectations and product revenue reached a new all-time high with 8% year-over-year constant-currency growth. Orders grew sequentially at a double-digit rate and net orders doubled; Accuray still has wor...
Accuray Incorporated (ARAY) Q2 2023 Earnings Conference Call February 1, 2023 16:30 ET Company Participants Jesse Chew - Senior Vice President, General Counsel & Corporate Secretary Suzanne Winter - Chief Executive Officer Ali Pervaiz - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care PR Newswire The Radixact System will be supplied with ClearRT ® , Synchrony ® , and the VOLO™ Ultra Optim...
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients PR Newswire MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement...